Virpax to Use Envelta™ IND Enabling Study Results for Two Additional IndicationsBusiness Wire • 06/21/21
Virpax Pharmaceuticals to Present at LD Micro Invitational XI Event on Wednesday, June 9th at 4:30 PM ETBusiness Wire • 06/02/21
Virpax Pharmaceuticals Reports 2021 First Quarter Results and Recent DevelopmentsBusiness Wire • 05/18/21
Virpax Pharmaceuticals Engages Torreya Capital to Advise on Global Partnering EffortsBusiness Wire • 04/22/21
Virpax's Liposomal Bupivacaine Candidate Associated With No Neurotoxicity In Animal StudiesBenzinga • 04/05/21
Virpax to Initiate Investigational New Drug (IND) Enabling Studies for Probudur(TM) for Postoperative PainAccesswire • 03/22/21